Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-exposure Prophylaxis”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Large-scale testing (Phase 3)Study completedNCT03662022
What this trial is testing

Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar

Who this might be right for
Leprosy
Institute of Tropical Medicine, Belgium 144,000
Not applicableLooking for participantsNCT06139354
What this trial is testing

Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

Who this might be right for
Hiv
University of Arkansas 45
Post-approval studies (Phase 4)Study completedNCT01214759
What this trial is testing

Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)

Who this might be right for
HIV
The University of Texas Health Science Center, Houston 103
Large-scale testing (Phase 3)Study completedNCT00115648
What this trial is testing

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

Who this might be right for
HIV Infections
Johns Hopkins Bloomberg School of Public Health 3,300
Post-approval studies (Phase 4)Looking for participantsNCT05745987
What this trial is testing

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

Who this might be right for
Monkeypox
McMaster University 3,000
Not applicableStudy completedNCT01177488
What this trial is testing

Innovative Service Delivery for Secondary Prevention of PTSD

Who this might be right for
PTSD
Charleston Research Institute 280
Large-scale testing (Phase 3)UnknownNCT04858633
What this trial is testing

Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19

Who this might be right for
Covid19COVID-19 Prevention
Post Graduate Institute of Medical Education and Research, Chandigarh 1,000
Not applicableStudy completedNCT04793750
What this trial is testing

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

Who this might be right for
HIV InfectionsSyphilis
Johns Hopkins University 419
Large-scale testing (Phase 3)UnknownNCT05667974
What this trial is testing

Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

Who this might be right for
RabiesPrevention
Yisheng Biopharma (Singapore) Pte. Ltd. 4,500
Not applicableStudy completedNCT05684185
What this trial is testing

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Who this might be right for
Rabies Post-exposure Prophylaxis
Institut Pasteur du Cambodge 215
Not applicableLooking for participantsNCT06592677
What this trial is testing

Early Support After Exposure to Trauma

Who this might be right for
Post-traumatic Stress Disorder
Norwegian Center for Violence and Traumatic Stress Studies 360
Early research (Phase 1)Active Not RecruitingNCT05890963
What this trial is testing

10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 20
Large-scale testing (Phase 3)Ended earlyNCT04721535
What this trial is testing

DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Who this might be right for
Covid19SARS-COV-2 Infection
Daewoong Pharmaceutical Co. LTD. 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055880
What this trial is testing

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Who this might be right for
Rabies
Sinovac Biotech Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT05639166
What this trial is testing

Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

Who this might be right for
COVID-19
Immune Biosolutions Inc 200
Large-scale testing (Phase 3)Study completedNCT01516970
What this trial is testing

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)

Who this might be right for
Human Immunodeficiency Virus (HIV)
Janssen-Cilag G.m.b.H 312
Large-scale testing (Phase 3)Study completedNCT05846568
What this trial is testing

Study to Evaluate GR1801's Efficacy and Safety

Who this might be right for
Rabies Post-exposure Prophylaxis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 1,200
Post-approval studies (Phase 4)UnknownNCT01053377
What this trial is testing

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes

Who this might be right for
Influenza
National Institute for Public Health and the Environment (RIVM) 900
Large-scale testing (Phase 3)Study completedNCT04328961
What this trial is testing

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

Who this might be right for
COVID-19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
University of Washington 943
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Load More Results